source
- Overseas MDMA and psilocybin makers eye U.S. market as regulatory landscape easesCompanies that produce MDMA and psilocybin for patients abroad are turning their attention to the United States, hoping to leverage experience gained under more permissive foreign rules. Rising pol…
- Bicara shakes up leadership ahead of CEO departure; J&J's John Reed joins Madrigal's board→ Some big changes are coming at Bicara Therapeutics, and it starts at the top. President and COO Ryan Cohlhepp will take over as CEO on Jan. 1, and Claire Mazumdar ...Endpoints · 23m ago↗ source
- FDA grants accelerated approval to Bristol Myers' iberdomide for relapsed or refractory multiple myeloma